The presented NMR-based metabolomics results obtained for patients with ALG13-CDG caused by a c.320A>G variant provide an interesting preliminary insight into the laboratory characteristics of one of the glycosylation disorders. This evidence concerns the gene ALG13 and disorder of glycosylation.